<DOC>
	<DOC>NCT00143442</DOC>
	<brief_summary>The purpose of this study is to determine the effectiveness of [S,S]-Reboxetine in the treatment of chronic pain following a shingles infection in patients who are Gabapentin treatment failures.</brief_summary>
	<brief_title>Study of [S,S]-Reboxetine in Patients With Postherpetic Neuralgia, Who Are Gabapentin Treatment Failures</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Neuralgia, Postherpetic</mesh_term>
	<mesh_term>Reboxetine</mesh_term>
	<mesh_term>Gabapentin</mesh_term>
	<criteria>Patients must have pain present for more than 3 months after the healing of shingles skin rash. Patients at screening must have a score &gt; or = 40 mm on the pain visual analogue scale. Patients with poor renal function. Patients with other severe pain, that may impair the selfassessment of the pain due to shingles. Patients with abnormal electrocardiogram.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2006</verification_date>
</DOC>